Can advanced edge enhancement software improve image quality to visualise tubes, catheters and wires in digital chest radiographs?

Introduction: This study aimed to test whether Advanced Edge Enhancement (AEE) software could improve the localisation of tubes, catheters or wires, while also affecting the overall image quality in chest x-rays (CXR).

Methods: In total, 50 retrospective CXRs were included. All images were obtained utilising the Canon X-ray system (CANON/Arcoma Precision T3 DR System, Canon Europe, Amsterdam, NL) with a CXDI-810C wireless detector.

Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.

Background: The objective was to determine clinical consequences of various specificities for the infant/fetus. The population was patients referred between 1998 and 2005 to the tertiary center because of detected red blood cell (RBC) alloimmunization. Altogether 455 infants were delivered by 390 alloimmunized women.

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial.

Background: Up to 3 years of treatment with alendronate, 5 mg/d, prevents postmenopausal bone loss.

Objective: To determine whether the effect of alendronate is sustained at 4 years of treatment and persists after treatment is discontinued.

Design: Randomized, controlled trial.

High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women.

A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis. Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm2, and 278 women had a BMD below 0.